Sven Hoffner

9.7k total citations · 3 hit papers
127 papers, 6.7k citations indexed

About

Sven Hoffner is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Sven Hoffner has authored 127 papers receiving a total of 6.7k indexed citations (citations by other indexed papers that have themselves been cited), including 109 papers in Infectious Diseases, 109 papers in Epidemiology and 39 papers in Surgery. Recurrent topics in Sven Hoffner's work include Tuberculosis Research and Epidemiology (107 papers), Mycobacterium research and diagnosis (93 papers) and Infectious Diseases and Tuberculosis (23 papers). Sven Hoffner is often cited by papers focused on Tuberculosis Research and Epidemiology (107 papers), Mycobacterium research and diagnosis (93 papers) and Infectious Diseases and Tuberculosis (23 papers). Sven Hoffner collaborates with scholars based in Sweden, France and China. Sven Hoffner's co-authors include Emma Huitric, Gunilla Källenius, Peter Verhasselt, Koen Andries, Jim Werngren, Emmanuelle Cambau, Hans Christian Winkler, Jef Van Gestel, Philip Timmerman and Jean‐Marc Neefs and has published in prestigious journals such as Science, New England Journal of Medicine and SHILAP Revista de lepidopterología.

In The Last Decade

Sven Hoffner

127 papers receiving 6.4k citations

Hit Papers

A Diarylquinoline Drug Active on the ATP Synthase of Myco... 2001 2026 2009 2017 2004 2001 2009 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. A Diarylquinoline Drug Active on the ATP Synthase of Mycobacterium tuberculosis
    2004 1.6k citations Koen Andries, Peter Verhasselt et al. Science profile →
  2. Global Trends in Resistance to Antituberculosis Drugs
    2001 519 citations Sven Hoffner, Mario Raviǵlione et al. profile →
  3. Emergence of New Forms of Totally Drug-Resistant Tuberculosis Bacilli
    2009 426 citations Ali Akbar Velayati, Mohammad Reza Masjedi et al. CHEST Journal profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sven Hoffner Sweden 39 5.1k 4.3k 1.8k 1.8k 667 127 6.7k
Timothy D. McHugh United Kingdom 48 5.7k 1.1× 4.5k 1.0× 2.0k 1.1× 1.9k 1.1× 815 1.2× 234 9.0k
C. Truffot-Pernot France 34 3.9k 0.8× 3.4k 0.8× 1.7k 0.9× 1.1k 0.6× 632 0.9× 96 5.1k
Nacer Lounis France 31 4.4k 0.9× 3.3k 0.8× 2.3k 1.3× 1.0k 0.6× 670 1.0× 59 5.8k
Stephen H. Gillespie United Kingdom 52 6.0k 1.2× 5.4k 1.3× 1.7k 1.0× 1.8k 1.0× 1.1k 1.6× 263 10.2k
Eric L. Nuermberger United States 51 6.6k 1.3× 4.6k 1.1× 2.5k 1.4× 1.4k 0.8× 878 1.3× 169 8.1k
Anne J. Lenaerts United States 42 3.2k 0.6× 2.3k 0.5× 1.9k 1.1× 703 0.4× 430 0.6× 93 5.0k
Michael H. Cynamon United States 41 2.9k 0.6× 2.5k 0.6× 1.5k 0.9× 553 0.3× 573 0.9× 132 4.8k
Béate Heym France 32 3.1k 0.6× 3.1k 0.7× 1.2k 0.7× 1.0k 0.6× 801 1.2× 79 4.6k
Anandi Martin Belgium 31 2.7k 0.5× 2.4k 0.6× 1.2k 0.7× 677 0.4× 467 0.7× 114 4.4k
David Alland United States 52 8.4k 1.6× 7.0k 1.6× 3.4k 1.9× 3.3k 1.9× 895 1.3× 135 11.7k

Countries citing papers authored by Sven Hoffner

Since Specialization
Citations

This map shows the geographic impact of Sven Hoffner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sven Hoffner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sven Hoffner more than expected).

Fields of papers citing papers by Sven Hoffner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sven Hoffner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sven Hoffner. The network helps show where Sven Hoffner may publish in the future.

Co-authorship network of co-authors of Sven Hoffner

This figure shows the co-authorship network connecting the top 25 collaborators of Sven Hoffner. A scholar is included among the top collaborators of Sven Hoffner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sven Hoffner. Sven Hoffner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hoffner, Sven, et al.. (2024). Novel and reported compensatory mutations in rpoABC genes found in drug resistant tuberculosis outbreaks. Frontiers in Microbiology. 14. 1265390–1265390. 3 indexed citations
2.
Mansjö, Mikael, et al.. (2022). Distribution of Common and Rare Genetic Markers of Second-Line-Injectable-Drug Resistance in Mycobacterium tuberculosis Revealed by a Genome-Wide Association Study. Antimicrobial Agents and Chemotherapy. 66(6). e0207521–e0207521. 8 indexed citations
3.
Thiede, Joshua M., Nicholas Dillon, Sven Hoffner, et al.. (2022). Pyrazinamide Susceptibility Is Driven by Activation of the SigE-Dependent Cell Envelope Stress Response in Mycobacterium tuberculosis. mBio. 13(1). e0043921–e0043921. 17 indexed citations
4.
Kardan-Yamchi, Jalil, et al.. (2021). The 7H11 Agar Medium Supplemented with Calf Bovine Serum for Susceptibility Testing of Mycobacterium tuberculosis Isolates Against Pyrazinamide. Microbial Drug Resistance. 27(12). 1652–1657. 1 indexed citations
5.
Walusimbi, Simon, Fred C. Semitala, Freddie Bwanga, et al.. (2016). Outcomes of a clinical diagnostic algorithm for management of ambulatory smear and Xpert MTB/Rif negative HIV infected patients with presumptive pulmonary TB in Uganda: a prospective study.. SHILAP Revista de lepidopterología. 23. 154–154. 5 indexed citations
6.
7.
Casali, Nicola, Vladyslav Nikolayevskyy, Yanina Balabanova, et al.. (2012). Microevolution of extensively drug-resistant tuberculosis in Russia. Genome Research. 22(4). 735–745. 141 indexed citations
8.
Sandegren, Linus, Ramona Groenheit, Tuija Koivula, et al.. (2011). Genomic Stability over 9 Years of an Isoniazid Resistant Mycobacterium tuberculosis Outbreak Strain in Sweden. PLoS ONE. 6(1). e16647–e16647. 27 indexed citations
9.
Farnia, Parissa, Mohammad Reza Masjedi, F Mohammadi, et al.. (2007). Colorimetric Detection of Multidrug-Resistant or Extensively Drug-Resistant Tuberculosis by Use of Malachite Green Indicator Dye. Journal of Clinical Microbiology. 46(2). 796–799. 30 indexed citations
10.
Mokrousov, Igor, Ho Minh Ly, Tatiana Otten, et al.. (2005). Origin and primary dispersal of the Mycobacterium tuberculosis Beijing genotype: Clues from human phylogeography. Genome Research. 15(10). 1357–1364. 140 indexed citations
11.
Andries, Koen, Peter Verhasselt, Jérôme Guillemont, et al.. (2004). A Diarylquinoline Drug Active on the ATP Synthase of Mycobacterium tuberculosis. Science. 307(5707). 223–227. 1632 indexed citations breakdown →
12.
13.
Hoffner, Sven, et al.. (2001). In vitro activity of PR-39, a proline-arginine-rich peptide, against susceptible and multi-drug-resistant Mycobacterium tuberculosis. Journal of Antimicrobial Chemotherapy. 47(5). 575–580. 73 indexed citations
14.
Schwoebel, V, Maria Luisa Moro, Francis Drobniewski, et al.. (2000). Recomendaciones europeas en materia de vigilancia de resistencias a fármacos antituberculosos. Eurosurveillance. 5(10). 104–106. 1 indexed citations
15.
16.
Bergan, Tom, et al.. (1996). Direct detection of Mycobacterium tuberculosis in respiratory samples from patients in Scandinavia by polymerase chain reaction. Clinical Microbiology and Infection. 2(2). 127–131. 8 indexed citations
17.
Dias, F., et al.. (1993). Drug susceptibility in Mycobacterium tuberculosis of a sample of patients in Guinea Bissau. Tubercle and Lung Disease. 74(2). 129–130. 14 indexed citations
18.
Hoffner, Sven, et al.. (1992). A biphasic system for primary isolation of mycobacteria compared to solid medium and broth culture. Journal of Medical Microbiology. 37(5). 332–334. 6 indexed citations
19.
Hillerdal, Gunnar, et al.. (1991). [A man caused a miniepidemic of animal tuberculosis--he infected his wife and cat].. PubMed. 88(13). 1216–7. 1 indexed citations
20.
Hoffner, Sven & Gunilla Källenius. (1988). Susceptibility of streptomycin-resistantMycobacterium tuberculosis strains to amikacin. European Journal of Clinical Microbiology & Infectious Diseases. 7(2). 188–190. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Timothy D. McHugh Breakdown of academic impact, for papers by C. Truffot-Pernot Breakdown of academic impact, for papers by Nacer Lounis Breakdown of academic impact, for papers by Stephen H. Gillespie Breakdown of academic impact, for papers by Eric L. Nuermberger Breakdown of academic impact, for papers by Anne J. Lenaerts Breakdown of academic impact, for papers by Michael H. Cynamon Breakdown of academic impact, for papers by Béate Heym Breakdown of academic impact, for papers by Anandi Martin Breakdown of academic impact, for papers by David Alland
Rankless by CCL
2026